Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiashi Biotechnology is a China-based biotechnology company focused on the discovery and development of innovative small molecule and biologic therapeutics. The company leverages a proprietary high-throughput screening and drug discovery platform to identify novel candidates for the treatment of oncology, autoimmune, and metabolic disorders. In addition to its internal pipeline, Jiashi provides contract research services (CRO) to global pharmaceutical and biotech partners, specializing in lead optimization and preclinical validation. The company operates facilities in Shanghai and Suzhou, positioning itself as an integrated player in the Chinese life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jia Shi.